Precedex Injection, Solution
Product Images NDC 0409-1660

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Precedex (NDC 0409-1660). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hospira, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Precedex 01)

FDA Label Image

Logo (Precedex 02)

FDA Label Image

Principal Display Panel (50 mL Bottle Label)

Precedex is a prescription drug in injection form, packaged in a 50 mL vial with an NDC number of 0409-1660-55. The medication is distributed by Hospira, Inc. and is intended for intravenous use. The drug contains 0.2% sodium chloride and has a concentration of 200 mcg/50 mL (4 mcg/mL). The text also includes a barcode for FP0-GS1 DataBar Stacked 10 mil.*

FDA Label Image

Principal Display Panel (50 mL Bottle Tray)

This is a medication labeled as Dexmedetomidine HCl, with a concentration of 200 mcg/50mL in a single-use bottle. The medication is meant for intraenous use and should be discarded if unused. The medication is distributed by Hospira, Inc in Lake Forest, Illinois. Not available.*

FDA Label Image

Principal Display Panel (100 mL Bottle Label)

Each vial contains 4.1mg of dexmedetomidine and is sterile, non-pyrogenic, clear, and colorless. This product is free from natural rubber latex. The recommended storage is at 20-25°C (68-77°F). The product is distributed by Hospira Inc. and has a barcode for identification. The above text also includes lot number and manufacturing date.*

FDA Label Image

Principal Display Panel (100 mL Bottle Tray)

This is a description of a medication containing 4 mcg dexmedetomidine provided as 472mcg dexmedetomidine HCland and 9 mg of sodium chloride In water for Injection. It is recommended to store it between 20 and 25°C (68 and 77°F), and it should not be frozen. The pH is 4.5 to 8.0, and it is preservative-free. The usual dosage can be found in the insert. It is made in Finland and distributed by Hospira, Inc., Lake Forest, IL 60045, USA. The remaining text is not-readable and contains a combination of letters, numbers, and symbols.*

FDA Label Image

Principal Display Panel (20 mL Vial Label)

This is a medication labeled as Dexmedetomidine HCl, which comes in a 20ml vial and is for intravenous use only. The usual dosage is not listed, and it should be stored at 20 to 25°C. It is not recommended to freeze it, and it does not contain natural rubber latex. The manufacturer is Hospira, Inc located in Lake Forest, IL. The lot number and expiration date are not available.*

FDA Label Image

Principal Display Panel (20 mL Vial Carton)

This is a description of a medication: PrecedexTM (Dexmedetomidine HCl in 0.9% Sodium Chloride Injection) is a solution with a concentration of 80 mcg/20 mL (4 meg/mL). The injection comes in a single-dose vial that has to be discarded if not completely used. The package contains 10 vials, each of 20 mL, having NDC 0409-166020. The medication is meant for intravenous use only. The usual dosage can be found in the insert. PrecedexTM must be stored at 20 - 25°C and should not be frozen. The solution is preservative-free. The label mentions that each 20 mL vial contains 4 mg dexmedetomidine HCl along with 9 mg Sodium chloride, dissolved in water for injection. The medication is manufactured in Finland and distributed by Hospira Inc. (Lake Forest, IL 60045, USA).*

FDA Label Image

Principal Display Panel (2 mL Vial Label)

This is a description of a medication called Precedex, containing dexmedetomidine hydrochloride in injection form. The medication is intended for intravenous use and must be diluted prior to administration. Each 2mL vial contains 200mcg/2mL (100 mcg/mL) of the active ingredient. The medication is only available by prescription and is distributed by Hospira Inc. in Lake Forest, IL. The provided NDC code is 0409-1638-32.*

FDA Label Image

Principal Display Panel (2 mL Vial Tray)

The text appears to be a product label and includes details such as the product code, size, dosage instructions and precautions. The product is Dexmedetomidine HCI Injection for intravenous use and must be diluted before use. The label also includes information on dilution and contains a warning that the product is a prescription drug and should be used only under medical supervision.*

FDA Label Image

Principal Display Panel (250 mL Bottle Label)

This is a description of a medication called Dexmedetomidine HCI, which comes in a 250mL bottle. Each mL of the medication contains 4mg of dexmedetomidine, which is provided as 4.72 meg dexmedetomidine HCI. It's a single-dose bottle, and any unused portions need to be discarded along with 9mg of sodium chloride. The medication has a pH of 8.0, and it's made with synthetic components not natural extracts. The medication is recommended for intravenous use and should not be frozen. It's distributed by Hospira, Inc. and it's a preservative-free medication.*

FDA Label Image

Principal Display Panel (250 mL Bottle Carton)

This text describes a drug called "Precedex" that contains Dexmedetomidine hydrochloride and is dissolved in 0.9% sodium chloride injection, with each milliliter containing 4 mcg of Dexmedetomidine. It is a single-dose bottle intended for intravenous use only, and unused portions should be discarded. The usual dosage is not mentioned and should be found elsewhere. The drug must be stored between 20 to 25°C and should not be frozen. The product is made in Finland and distributed by Hospira, Inc. The text also contains information about the National Drug Code (NDC) and other identifications.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.